Theralase Technologies Inc. (CVE:TLT – Get Free Report)’s stock price shot up 2.9% on Wednesday . The stock traded as high as C$0.18 and last traded at C$0.18. 61,000 shares traded hands during trading, a decline of 48% from the average session volume of 117,903 shares. The stock had previously closed at C$0.18.
Theralase Technologies Trading Up 2.9 %
The business has a 50-day moving average price of C$0.24 and a 200-day moving average price of C$0.25. The company has a quick ratio of 3.40, a current ratio of 1.91 and a debt-to-equity ratio of 14.85. The firm has a market capitalization of C$43.83 million, a P/E ratio of -9.59 and a beta of 1.36.
Theralase Technologies Company Profile
Theralase Technologies Inc, a clinical stage pharmaceutical company, engages in the research and development of light activated photo dynamic compounds (PDCs) and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions.
See Also
- Five stocks we like better than Theralase Technologies
- The Most Important Warren Buffett Stock for Investors: His Own
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Utilities Stocks Explained – How and Why to Invest in Utilities
- The 3 Most Talked About Investments on WallStreetBets Right Now
- How to Evaluate a Stock Before Buying
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Theralase Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theralase Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
